Coeptis Therapeutics Holdings Profit Margin

Coeptis Therapeutics Holdings (COEP) currently reports a profit margin of -633.94% as of March 2026. That compares with -512.37% in the prior-year period — down 23.7% year over year. That is below the sector sector average of 19.69%. Use the charts on this page to explore Coeptis Therapeutics Holdings's profit margin history and peer comparisons.

Coeptis Therapeutics Holdings's profit margin decreased from -512.37% to -633.94% — a 23.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Coeptis Therapeutics Holdings's profit margin of -633.94% is lower than the its sector sector average of 19.69%. That is roughly 3319.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Coeptis Therapeutics Holdings's current -633.94% should be judged against industry norms (sector average: 19.69%) and against COEP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -633.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.69%. From there, open related valuation or income-statement pages for Coeptis Therapeutics Holdings, and consider following COEP for alerts when major investors trade the stock.